Videos & Visuals
OverviewCertain signs and symptoms can increase suspicion for transthyretin amyloid cardiomyopathy (ATTR-CM) even before clear cardiac involvement is present.…
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Marina Carter, PharmD, BCACP, Ambulatory Clinical Pharmacy Specialist with Carilion…
Greg Foster, 4-time world champion and Olympic Silver medalist, discusses his journey to diagnosis. Learn more about his initial symptoms, multiple doctors visits,…
Kevin M. Alexander, MD, eagerly awaits the presentation of new amyloid dataat the 2026 ACC meeting in New Orleans and is especially interested in the subgroup…
Welcome back to another AJMC Payer Perspectives series. In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and…
Long-term survival benefits were seen in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) using the drug acoramidis (Attruby) in new data presented at…
In 2015, Jack started to have shortness of breath. It wouldn't go away and became impossible to ignore.
In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related…
